[go: up one dir, main page]

ZA200904912B - Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors - Google Patents

Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors

Info

Publication number
ZA200904912B
ZA200904912B ZA200904912A ZA200904912A ZA200904912B ZA 200904912 B ZA200904912 B ZA 200904912B ZA 200904912 A ZA200904912 A ZA 200904912A ZA 200904912 A ZA200904912 A ZA 200904912A ZA 200904912 B ZA200904912 B ZA 200904912B
Authority
ZA
South Africa
Prior art keywords
preparation
kinase inhibitors
quinazoline derivatives
substituted pyrazolo
pyrazolo
Prior art date
Application number
ZA200904912A
Inventor
Michele Caruso
Italo Beria
Maria Grabriella Brasca
Ron Ferguson
Helena Posteri
Barbara Valsasina
Original Assignee
Nerviano Medical Sciences Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nerviano Medical Sciences Srl filed Critical Nerviano Medical Sciences Srl
Publication of ZA200904912B publication Critical patent/ZA200904912B/en

Links

ZA200904912A 2006-12-21 2007-12-17 Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors ZA200904912B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06126902 2006-12-21

Publications (1)

Publication Number Publication Date
ZA200904912B true ZA200904912B (en) 2010-09-29

Family

ID=41221550

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200904912A ZA200904912B (en) 2006-12-21 2007-12-17 Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors

Country Status (3)

Country Link
CN (1) CN101563351B (en)
UA (1) UA102219C2 (en)
ZA (1) ZA200904912B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107383019B (en) * 2017-07-28 2019-10-15 江苏艾凡生物医药有限公司 Pyrazolo[4,3-h]quinazoline compounds and uses thereof
CN111094291B (en) * 2017-08-11 2022-06-21 晟科药业（江苏）有限公司 1H-pyrazolo[4,3-H]quinazolines as protein kinase inhibitors
CN114685520B (en) * 2020-12-25 2024-08-30 武汉誉祥医药科技有限公司 Tri-fused ring compound and pharmaceutical composition and application thereof
WO2022143576A1 (en) * 2020-12-31 2022-07-07 恒元生物医药科技(苏州)有限公司 Pyrazoloquinazoline compound, and preparation method therefor and use thereof
EP4289852A4 (en) * 2021-02-08 2025-02-26 NovaOnco JS Therapeutics Co., Ltd. 5,6-DIHYDROTHIENO[3,4-H QUINAZOLINE COMPOUND
EP4446325A4 (en) 2021-12-10 2025-04-16 Shandong Luye Pharmaceutical Co., Ltd. Protein kinase inhibitor, preparation method therefor, and application thereof
CN119630674A (en) * 2022-08-08 2025-03-14 江苏星盛新辉医药有限公司 A salt form, a crystal form and a preparation method thereof of a 5,6-dihydrothieno[3,4-h]quinazoline compound
WO2024153110A1 (en) * 2023-01-17 2024-07-25 北京哲源科技有限责任公司 Stereoisomer and deuterated derivative of pyrazoloquinazoline compound and use
CN117683035A (en) * 2023-11-27 2024-03-12 成都睿智化学研究有限公司 A kind of synthetic method of substituted pyrazoquinazoline derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1476431A1 (en) * 2002-02-19 2004-11-17 Pharmacia Corporation Tricyclic pyrazole derivatives for the treatment of inflammation
EA010904B1 (en) * 2003-05-22 2008-12-30 НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors

Also Published As

Publication number Publication date
UA102219C2 (en) 2013-06-25
CN101563351A (en) 2009-10-21
CN101563351B (en) 2013-06-05

Similar Documents

Publication Publication Date Title
IL199323A (en) Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
IL206394A (en) 2-benzylpyridazinone derivatives as met kinase inhibitors, process for their preparation and medicaments and use thereof
SI2201012T1 (en) Pyrrološ2,3-dćpyrimidin derivatives as protein kinase b inhibitors
EP2211615A4 (en) Pyridosulfonamide derivatives as pi3 kinase inhibitors
IL196554A0 (en) Heteroaryl derivatives as protein kinase inhibitors
TWI349672B (en) Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
EP2046333A4 (en) Thiozolidinedione derivatives as p13 kinase inhibitors
EP2154965A4 (en) Naphthyridine, derivatives as p13 kinase inhibitors
IL184674A0 (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
IL198171A0 (en) Dihydropyridine derivatives useful as protein kinase inhibitors
PL2193133T3 (en) Imidazolothiadiazoles for use as protein kinase inhibitors
IL186845A0 (en) Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
ZA201004055B (en) 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors
EP2365809B8 (en) Pyrazinopyrazines and derivatives as kinase inhibitors
ZA201008387B (en) Azacarboline derivatives,preparation thereof,and therapeutic use thereof as kinase inhibitors
EP2239261A4 (en) Pyrrolopyrimidin derivative for use as pi3k inhibitor, and use thereof
IL193236A0 (en) Novel pyrone-indole derivatives and process for their preparation
EP1993535A4 (en) Thiazolones for use as pi3 kinase inhibitors
ZA200904912B (en) Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
IL196000A0 (en) 2-arylindole derivatives as npges-i inhibitors
IL194491A0 (en) Thiazolyldihydroindazole derivatives as protein kinase inhibitors
EP1993537A4 (en) Thiazolones for use as pi3 kinase inhibitors
EP1993536A4 (en) Thiazolones for use as pi3 kinase inhibitors
ZA200709732B (en) Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
EP1993538A4 (en) Thiazolones for use as pi3 kinase inhibitors